Colon cancer is the is the third most common type of cancer, causing death, with a survival rate of 5 years usually treated with chemotherapy or surgery. Many chemotherapeutic drugs are tested, but they have limitations such as resistance development, toxicity, limited response in advanced stages, and a lot of adverse side effects. To combat this problem, the current study focuses on vitexin, a phytochemical that has anti-inflammatory, anti-cancer, and anti-oxidant properties, is tested on HCT-116 cell lines as a chemotherapeutic drug for colon cancer. The present study proves that the phyto compound vitexin can upregulate the estrogen receptor genes and downregulate c-myc gene, which indicates that vitexin is a good therapeutic agent and induces the estrogen-mediated pathway on the regulation of cancer cell growth.
Vani S, Sivathanu B. Regulation of estrogen receptor-mediated apoptosis by vitexin in human colorectal carcinoma cells. J Appl Pharm Sci. 2025. Article in Press. http://doi.org/10.7324/JAPS.2025.261688
1. Siegel RL, Giaquinto AN, Jemal A, Cancer statistics. CA A Cancer J Clinicians. 2024;74(1):12–49. doi: https://doi.org/10.3322/caac.21820
2. Adigun AO, Adebile TM, Okoye C, Ogundipe TI, Ajekigbe OR, Mbaezue RN, et al. Causes and prevention of early-onset colorectal cancer. Cureus 2023;15(9):45095. doi: https://doi.org/10.7759/cureus.45095
3. Doria-Rose VP, Newcomb PA, Levin TR. Incomplete screening flexible sigmoidoscopy associated with female sex, age, and increased risk of colorectal cancer. Gut 2005;54(9):1273–8. doi: https://doi.org/10.1136/gut.2005.064030
4. Ashique S, Bhowmick M, Pal R, Khatoon H, Kumar P, Sharma H, et al. Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success. Advan Cancer Biol - Metastasis. 2024;1(10):100114. https://doi.org/10.1016/j.adcanc.2024.100114
5. Baliyan S, Mukherjee R, Priyadarshini A, Vibhuti A, Gupta A, Pandey RP, et al. Determination of antioxidants by DPPH radical scavenging activity and quantitative phytochemical analysis of Ficus religiosa. Molecules 2022;27(4):1326. doi: https://doi.org/10.3390/molecules27041326
6. Huang J, Zhou Y, Zhong X, Su F, Xu L. Effects of vitexin, a natural flavonoid glycoside, on the proliferation, invasion, and apoptosis of human U251 glioblastoma cells. Oxid Med Cell Longev. 2022;2:3129155. doi: https://doi.org/10.1155/2022/3129155
7. Das PK, Saha J, Pillai S, Lam AY, Gopalan V, Islam F. Implications of estrogen and its receptors in colorectal carcinoma. Cancer Med. 2023;12:4367–79. doi: https://doi.org/10.1002/cam4.5242
8. Bolt MJ, Oceguera J, Singh PK, Safari K, Abbott DH, Neugebauer KA, et al. Characterization of flavonoids with potent and subtype-selective actions on estrogen receptors alpha and beta. Iscience 2024;27(3):109275. doi: https://doi.org/10.1016/j.isci.2024.109275
9. Chaput G, Sumar N. Endocrine therapies for breast and prostate cancers. Can Fam Physician. 2022;68(4):271–6. doi: https://doi.org/10.46747/cfp.6804271
10. Barnum KJ, O Connell MJ.Cell cycle regulation by checkpoints. Methods Mol Biol. 2014;1170:29–40. doi: https://doi.org/10.1007/978-1-4939-0888-2_2
11. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495–516. doi: https://doi.org/10.1080/01926230701320337
12. Bobadilla AV, Arévalo J, Sarró E, Byrne HM, Maini PK, Carraro T, et al. In vitro cell migration quantification method for scratch assays. J Royal Society Inter. 2019;16(151):20180709. doi: https://doi.org/10.1098/rsif.2018.0709
13. Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: impact on human health. Pharmacogn Rev. 2010;4(8):118–26. doi: https://doi.org/10.4103/0973-7847.70902
14. Ayala A, Munoz MF, Arguelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014:360438. doi: https://doi.org/10.1155/2014/360438
15. Bai Y, Chang J, Xu Y, Cheng D, Liu H, Zhao Y, et al. Antioxidant and myocardial preservation activities of natural phytochemicals from mung bean (Vigna radiata L.) seeds. J Agric Food Chem. 2016;64(22):4648–55. doi: https://doi.org/10.1021/acs.jafc.6b01538
16. Bhardwaj M, Cho HJ, Paul S, Jakhar R, Khan I, Lee SJ, et al. Vitexin induces apoptosis by suppressing autophagy in multi-drug resistant colorectal cancer cells. Oncotarget 2017;9(3):3278–91. doi: https://doi.org/10.18632/oncotarget.22890
17. Xu L, Pelosof L, Wang R, McFarland HI, Wu WW, Phue JN, et al. NGS evaluation of colorectal cancer reveals interferon gamma dependent expression of immune checkpoint genes and identification of novel IFNγ induced genes. Front Immunol. 2020;19(11):224. doi: https://doi.org/10.3389/fimmu.2020.00224
18. Chen D, Chen Y, Huang F, Zhang X, Zhou Y, Xu L. The underlying regulatory mechanisms of colorectal carcinoma by combining Vitexin and Aspirin: based on systems biology, molecular docking, molecular dynamics simulation, and in vitro study. Front Endocrinol. 2023;26(14):1147132. doi: https://doi.org/10.3389/fendo.2023.1147132
19. Hidalgo-Estevez AM, Stamatakis K, Jimenez-Martinez M, Lopez- Perez R, Fresno M. Cyclooxygenase 2-regulated genes an alternative avenue to the development of new therapeutic drugs for colorectal cancer. Front Pharmacol. 2020;29(11):533.
20. Lynch ML, Brand MI. Preoperative evaluation and oncologic principles of colon cancer surgery. Clin Colon Rectal Surg. 2005;18(3):163–73. doi: https://doi.org/10.3389/fphar.2020.00533
21. Brierley J, Gospodarowicz M, O’Sullivan B. The principles of cancer staging. Ecancermedicalscience 2016;24:10, doi: https://doi.org/10.3332/ecancer.2016.ed61. eCollection 2016
22. Ijaz MU, Tahir A, Ahmed H, Ashraf A, Ahmedah HT, Muntean L, et al. Chemoprotective effect of vitexin against cisplatin-induced biochemical, spermatological, steroidogenic, hormonal, apoptotic and histopathological damages in the testes of Sprague-Dawley rats. Saudi Pharm J.2022;30(5):519–26. doi: https://doi.org/10.1016/j.jsps.2022.03.001
23. Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713–32. doi: https://doi.org/10.1038/s41575-019-0189-8
24. Mustapha M, Mat Taib CN. Beneficial role of vitexin in Parkinson’s disease. Malays J Med Sci. 2023;30(2):8–25. doi: https://doi.org/10.21315/mjms2023.30.2.2
25. Williams C, DiLeo A, Niv Y, Gustafsson JÅ. Estrogen receptor beta as target for colorectal cancer prevention. Cancer Lett. 2016;372(1):48–56. doi: https://doi.org/10.1016/j.canlet.2015.12.009
26. Almeida M, Laurent MR, Dubois V, Claessens F, O’Brien CA, Bouillon R, et al. Estrogens and androgens in skeletal physiology and pathophysiology. Physiol Rev. 2017;97(1):135–87. doi: https://doi.org/10.1152/physrev.00033.2015
27. Huang J, Zhou Y, Zhong X, Su F, Xu L. Effects of vitexin, a natural flavonoid glycoside, on the proliferation, invasion, and apoptosis of human U251 glioblastoma cells. Oxid Med Cell Longev. 2022;2:3129155. doi: https://doi.org/10.1155/2022/3129155
28. Chen S, Li X, Zhang J, Li L, Wang X, Zhu Y, et al. Six mutator-derived lncRNA signature of genome instability for predicting the clinical outcome of colon cancer. J Gastrointest Oncol. 2021;12(5):2157–71. doi: https://doi.org/10.21037/jgo-21-494
29. Kurutas EB. The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutr J.2016;25(15):71. doi: https://doi.org/10.1186/s12937-016-0186-5
30. Fiorillo C, Quero G, Longo F, Mascagni P, Delvaux M, Mutter D. Capsule endoscopy versus colonoscopy in patients with previous colorectal surgery: a prospective comparative study. Gastroenterol Res. 2020;13(5):217–24. doi: https://doi.org/10.14740/gr1309
31. Lo EK, Lee JC, Turner PC, El-Nezami H. Low dose of zearalenone elevated colon cancer cell growth through G protein-coupled estrogenic receptor. Sci Rep. 2021;11(1):7403. doi: https://doi.org/10.1038/s41598-021-86788-w
32. Raw?uszko-Wieczorek AA, Lipowicz J, Nowacka M, Ostrowska K, Pietras P, Blatkiewicz M, et al. Estrogen receptor β affects hypoxia response in colorectal cancer cells. Biochim Biophys Acta Mol Basis Dis. 2024;1870(1):166894. doi: https://doi.org/10.1016/j.bbadis.2023.166894
33. Waldner MJ, Foersch S, Neurath MF. Interleukin-6--a key regulator of colorectal cancer development. Int J Biol Sci. 2012;8(9):1248–53. doi: https://doi.org/10.7150/ijbs.4614
34. Kobelt D, Zhang C, Clayton-Lucey IA, Glauben R, Voss C, Siegmund B, et al. Pro-inflammatory TNF-α and IFN-γ promote tumor growth and metastasis via induction of MACC1. Front Immunol. 2020;27(11):980. doi: https://doi.org/10.3389/fimmu.2020.00980
35. Jacenik D, Beswick EJ, Krajewska WM, Prossnitz ER. G protein-coupled estrogen receptor in colon function, immune regulation and carcinogenesis. World J Gastroenterol. 2019;25(30):4092–104. doi: https://doi.org/10.3748/wjg.v25.i30.4092
36. Lu L, Zhang Q, Shen X, Zhen P, Marin A, Garcia-Milian R, et al. Asparagine synthetase and G-protein coupled estrogen receptor are critical responders to nutrient supply in KRAS mutant colorectal cancer, Int J Cancer. 2025;156(1):52–68. doi: https://doi.org/10.1101/2023.05.05.539577
37. Yamane K, Toumazou C, Tsukada YI, Erdjument-Bromage H, Tempst P, Wong J, et al. JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell 2006;125(3):483–95. doi: https://doi.org/10.1016/j.cell.2006.03.027
38. Katz TA. Potential mechanisms underlying the protective effect of pregnancy against breast cancer: a focus on the IGF pathway. Front Oncol. 2016;6:228. doi: https://doi.org/10.3389/fonc.2016.00228
39. Hu K, Babapoor-Farrokhran S, Rodrigues M, Deshpande M, Puchner B, Kashiwabuchi F, et al. Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma. Oncotarget 2016;9:7(7):7816–28. doi: https://doi.org/10.18632/oncotarget.6868
40. Lee SH, Park YK, Lee DJ, Kim KM. Colonoscopy procedural skills and training for new beginners. World J Gastroenterol. 2014;20(45):16984. doi: https://doi.org/10.3322/caac.21820
41. Qiu Y, Waters CE, Lewis AE, Langman MJS, Eggo MC. Oestrogen-induced apoptosis in colonocytes expressing oestrogen receptor. J Endo. 2002;174:369–77. doi: https://doi.org/10.1677/joe.0.1740369.
42. Chimento A, De Luca A, Avena P, De Amicis F, Casaburi I, Sirianni R, et al. Estrogen receptors-mediated apoptosis in hormone-dependent cancers. Int J Mol Sci. 2022;23(3):1242. doi: https://doi.org/10.3390/ijms23031
Year
Month